MASOLA, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 1.967
EU - Europa 1.965
AS - Asia 1.288
SA - Sud America 180
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.432
Nazione #
US - Stati Uniti d'America 1.935
RU - Federazione Russa 771
SG - Singapore 526
GB - Regno Unito 409
CN - Cina 376
IT - Italia 212
BR - Brasile 137
SE - Svezia 127
VN - Vietnam 126
FR - Francia 116
HK - Hong Kong 98
IE - Irlanda 87
FI - Finlandia 82
DE - Germania 80
KR - Corea 41
AR - Argentina 23
UA - Ucraina 23
IN - India 20
ID - Indonesia 18
BD - Bangladesh 13
BE - Belgio 13
AT - Austria 11
CA - Canada 11
MX - Messico 10
TR - Turchia 10
ZA - Sudafrica 9
IL - Israele 7
NG - Nigeria 7
JP - Giappone 6
CH - Svizzera 5
EC - Ecuador 5
ES - Italia 5
IQ - Iraq 5
RO - Romania 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
MA - Marocco 4
PK - Pakistan 4
PL - Polonia 4
PS - Palestinian Territory 4
CL - Cile 3
LB - Libano 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
NL - Olanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.432
Città #
Southend 355
Moscow 274
Chandler 271
Singapore 270
Ashburn 231
San Jose 153
Jacksonville 136
Woodbridge 130
Dallas 110
Ann Arbor 96
Hong Kong 96
Dublin 85
Beijing 80
The Dalles 55
Verona 55
Houston 47
Wilmington 40
New York 38
Lawrence 37
Princeton 37
Ho Chi Minh City 29
Los Angeles 27
Nanjing 22
Redondo Beach 21
Columbus 20
Council Bluffs 20
Dong Ket 20
Shenyang 20
Helsinki 19
Jinan 19
Hanoi 18
Redmond 17
São Paulo 16
Buffalo 15
Munich 14
Brussels 13
Tianjin 13
Jakarta 11
Santa Clara 11
Seattle 11
Hebei 10
Milan 10
Vienna 10
Boardman 9
Orem 9
Taizhou 9
Denver 8
Guangzhou 8
Jiaxing 8
Ningbo 8
Brooklyn 7
Chicago 7
Frankfurt am Main 7
Johannesburg 7
Nanchang 7
Padova 7
Phoenix 7
Rome 7
Stockholm 6
Tokyo 6
Turku 6
Zhengzhou 6
Abuja 5
Chennai 5
Da Nang 5
Fairfield 5
Hangzhou 5
Istanbul 5
Montreal 5
San Francisco 5
Shanghai 5
Sindelfingen 5
Auburn Hills 4
Barnet 4
Catanzaro 4
Changsha 4
Genova 4
Hải Dương 4
Kochi 4
Lancaster 4
London 4
Norwalk 4
Querétaro 4
Quito 4
Rio de Janeiro 4
Seoul 4
Toronto 4
Warsaw 4
Biên Hòa 3
Buenos Aires 3
Cabo Frio 3
Campinas 3
Conselheiro Lafaiete 3
Detroit 3
Florence 3
Fuzhou 3
Governador Valadares 3
Haikou 3
Kent 3
Novokuznetsk 3
Totale 3.271
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 256
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 252
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 199
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 185
mTOR inhibitors and renal allograft: Yin and Yang. 184
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. 181
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 180
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 180
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 177
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 176
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 171
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 161
Sulodexide and glycosaminoglycans in the progression of renal disease. 159
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 159
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 157
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 152
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 150
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 146
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 146
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 143
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells 143
Heparanase as a target in cancer therapy. 142
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 142
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. 138
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 138
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 138
Heparanase: another renal player controlled by vitamin d. 134
Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion 130
L: -citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 127
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 126
Endothelial Glycocalyx as a Regulator of Fibrotic Processes 114
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. 106
LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase 104
The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells 93
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 90
Impact of heparanase on renal fibrosis. 83
Role of Heparanase in Tumor Progression: Molecular Aspects and Therapeutic Options 67
Totale 5.529
Categoria #
all - tutte 17.699
article - articoli 17.014
book - libri 0
conference - conferenze 685
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 0 0 0 0 3 33 45
2021/2022280 26 48 4 54 4 9 10 22 7 8 17 71
2022/2023673 51 92 65 103 64 137 15 39 80 4 16 7
2023/2024255 16 25 25 12 32 42 9 19 1 17 45 12
2024/2025740 45 43 30 131 33 30 47 35 118 30 67 131
2025/20262.130 162 95 110 372 619 163 218 121 130 140 0 0
Totale 5.529